Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: Implications for prophylactic automatic implantable cardioverter-defibrillator use

1993 ◽  
Vol 36 (3) ◽  
pp. 179-194 ◽  
Author(s):  
David J. Wilber ◽  
Douglas Kopp ◽  
Brian Olshansky ◽  
John G. Kall ◽  
Charles Kinder
Keyword(s):  
Myocardial Infarction ◽  
Ventricular Tachycardia ◽  
High Risk ◽  
Implantable Cardioverter Defibrillator ◽  
Cardioverter Defibrillator ◽  
Nonsustained Ventricular Tachycardia ◽  
Automatic Implantable Cardioverter Defibrillator ◽  
Risk Predictors

scholarly journals Surgery for Ventricular Tachycardia

2021 ◽  
pp. 36-42
Author(s):  
Gerald M Lawrie
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Implantable Cardioverter Defibrillator ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Surgical Ablation ◽  
Cardioverter Defibrillator ◽  
Automatic Implantable Cardioverter Defibrillator ◽  
Improved Methods

The treatment of drug-refractory chronic ventricular tachycardia (VT) has undergone a revolution over the last 50 years. We now have automatic implantable cardioverter defibrillator therapy with pace-terminating capabilities, and catheter ablation of VT has refined mapping and improved methods of lesion generation. Between 1980 and 1993, Houston Methodist Hospital became a leader in the diagnosis and surgical ablation of VT and other arrhythmias. This is a brief account of that period and some of the experiences and lessons that have led to significant advances used today.

The Automated Implantable Cardioverter

1991 ◽  
Vol 2 (1) ◽  
pp. 170-177 ◽  
Author(s):  
Rozann DeBorde ◽  
Diana Aarons ◽  
Madalyn Biggs
Keyword(s):  
Ventricular Tachycardia ◽  
Ventricular Fibrillation ◽  
Implantable Cardioverter Defibrillator ◽  
Nursing Interventions ◽  
Cardioverter Defibrillator ◽  
Patient Interactions ◽  
Automatic Implantable Cardioverter Defibrillator

The automatic implantable cardioverter defibrillator (AICD) is becoming the treatment of choice for patients with ventricular tachycardia and ventricular fibrillation. The widespread use of the AICD is requiring nurses in a variety of settings to become familiar with the device and device-patient interactions. This article attempts to define specific issues and nursing interventions relative to the AICD

Radiofrequency catheter ablation for ventricular tachycardia in ischaemic cardiomyopathy due to Kawasaki disease

2018 ◽  
Vol 28 (6) ◽  
pp. 890-893
Author(s):  
Hisaaki Komaki ◽  
Takashi Nakashima ◽  
Shinya Minatoguchi
Keyword(s):  
Myocardial Infarction ◽  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Kawasaki Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Radiofrequency Catheter Ablation ◽  
Post Myocardial Infarction ◽  
Cardioverter Defibrillator ◽  
Prior Myocardial Infarction ◽  
Ischaemic Cardiomyopathy

AbstractIn some patients with Kawasaki disease, a prior myocardial infarction causes ventricular tachycardia in the chronic post-myocardial infarction phase. We report the case of a 41-year-old man with symptomatic and haemodynamically unstable ventricular tachycardia in whom substrate ablation was performed for the ventricular tachycardia before insertion of an implantable cardioverter-defibrillator.

Sign in / Sign up

Export Citation Format

Share Document